Surgical Treatment of Peritoneal Carcinomatosis from Gastric Cancer
Author(s) -
Kiran K. Turaga,
T. Clark Gamblin,
Sam G. Pappas
Publication year - 2012
Publication title -
international journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 22
eISSN - 2090-1410
pISSN - 2090-1402
DOI - 10.1155/2012/405652
Subject(s) - medicine , peritoneal carcinomatosis , hyperthermic intraperitoneal chemotherapy , cytoreductive surgery , cancer , intraperitoneal chemotherapy , disease , intensive care medicine , carcinosis , surgery , pathology , ovarian cancer , colorectal cancer
Peritoneal carcinomatosis from gastric cancer is considered a fatal disease with limited treatment options. Recent advances in the understanding of the disease process, systemic chemotherapy, and application of cytoreductive surgery and hyperthermic chemoperfusion have shown promising results in the management of this difficult disease. Novel therapies such as extensive intraperitoneal lavage and intraperitoneal targeted agents are being applied in the management of this disease. We review the current literature in this field and describe the rationale behind some of these advances.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom